Categories
Part C Medicare Advantage Part D Prescription Drug

About the Medicare GLP-1 Bridge Program

Beginning July 1, 2026, a new federal initiative called the Medicare GLP-1 Bridge Program will allow individuals enrolled in a Part D plan to access certain highly sought-after weight-loss drugs for a flat copay of $50 a month.

According to the Centers for Medicare & Medicaid Services (CMS), this temporary demonstration program will run through December 31, 2027. The goal is to make these treatments more affordable while the government evaluates long-term coverage models.

Here are the essential details you need to know about who qualifies, what is covered, and how to get started.

1. Who Is Eligible?

You must be enrolled in a standalone Medicare Part D prescription drug plan or a Medicare Advantage plan that includes drug coverage. (This excludes the MA-Only plans that do not include drug coverage.) However, because this is a medical demonstration, you cannot simply request the $50 rate at the pharmacy counter. Your doctor must submit a Prior Authorization showing you meet specific medical categories based on your Body Mass Index (BMI):

  • Tier 1: A BMI of 35 or higher (no other health conditions required).

  • Tier 2: A BMI of 30 to 34.9 plus at least one of these conditions: heart failure, uncontrolled high blood pressure, or chronic kidney disease.

  • Tier 3: A BMI of 27 to 29.9 plus at least one of these conditions: pre-diabetes, a history of a heart attack, a history of a stroke, or peripheral artery disease.

Note: The program specifically excludes patients who have Type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease, as those individuals are typically already eligible for GLP-1 coverage directly through standard Part D plans.

2. Which Medications Are Included?

The $50 monthly price is the result of a negotiated agreement between the federal government and certain drug manufacturers. The program strictly covers specific brand-name formulations prescribed specifically for weight management:

  • Wegovy® (both the standard injectable and the newer oral tablet versions).

  • Zepbound® (strictly limited to the KwikPen® formulation; standard single-dose vials or pens are not covered).

  • Foundayo® (Eli Lilly’s newly approved oral pill).

Medications like Ozempic® and Mounjaro® are not part of this $50 weight-loss program because they are FDA-approved to treat Type 2 diabetes and are already handled under standard Medicare Part D formularies.

3. The “Fine Print” Seniors Need to Know

Because the Bridge program operates entirely outside of the traditional Medicare Part D design, there are a few unique rules to keep in mind:

  • Out-of-Pocket Limits: The $50 monthly copay does not count toward your standard Part D deductible or your annual $2,100 out-of-pocket maximum.

  • Extra Help: Because the program includes a flat $50 copay for everyone who qualifies, the federal Low Income Subsidy (Extra Help) and New York State EPIC cost-sharing protections do not apply to this program.

  • Supply Limits: The program will only cover 28-day or 30-day supplies at a time.

How to Take Action

You do not need to sign up for a new insurance plan to participate. If you think you meet the BMI and health criteria, schedule an appointment with your doctor. Your physician will need to write the prescription with specific instructions for the Bridge program, and they will submit the required medical paperwork directly to the program’s central processor (managed by Humana) to approve your $50 rate. You may want to provide your provider with a copy of the CMS Prescriber Guide and the CMS Pharmacy Operational Framework. for their review.

Click below and watch our June 9 “Ask the Experts” interview where Chris, Kate and I answer some questions about the GLP-1 Bridge Program:


An interesting article comparing several GLP-1 medications: https://www.health.com/glp-1s-weight-loss-8674445

 

Categories
Part D Prescription Drug

Part D Sticker Shock

I heard from a client who had just returned from picking up and paying for a tier 4 medication at her pharmacy and was shocked at the co-payment of $837.73. She knew her Part D drug plan has a deductible on higher tier medications, meaning she pays the full amount of the drug cost up to the deductible amount, and that higher tier medications have higher cost sharing. Still, she asked “I was able to pay this but how are other people supposed to come up with $800 on the spot?”

Medicare Prescription Payment Plan (PPP)
Click image for page 83 “Medicare and You 2026”

I mentioned that the PPP allows individuals to spread that high cost of their Medicare Part D prescription drugs over the rest of the year; as monthly payments instead of all at once. A few points on this:

  • This payment plan applies only to covered Part D drugs – not Part B medications administered in a doctor’s office.
  • The M3P is voluntary and so enrollment is not automatic. If you want to spread those higher costs out in installment payments, you must opt-in by contacting your plan’s customer service number provided on your 2026 plan ID card.
  • Beginning January 1, your pharmacist is supposed to provide information on this. However if they cannot assist with the actual opt-in, call your plan’s customer service number.
  • If you expect high out of pocket costs soon, you can opt-in now – call your Part D plan’s customer service number. Of course, you can opt-in at any time later in 2026, too.
  • Under certain urgent circumstances, you may opt-in to the payment plan retroactive IF:
    • A delay in filling the medication while waiting for the PPP processing would have jeopardized your health, and
    • You contact your Part D plan to opt-in within 72 hours of having picked up and paid for the medication. Be sure to keep the receipt showing the medication, date and payment amount.
  • This may not be the best choice for you if you already receive help paying for drugs through NY EPIC, Extra Help or Medicare Savings Program.
  • You’ll find more information at https://www.medicare.gov/prescription-payment-plan/will-this-help-me
OUT-OF-POCKET LIMIT ON DRUG COSTS

As a reminder, once your Part D drug costs (deductible, co-payments and other credits combined) reach $2,100, your cost for covered Part D medications will be reduced to $0 through December 31, 2026.

Categories
Medicare Part D Prescription Drug

The New Law and Medicare Part D

The US House and Senate has passed a bill (H.R. 5376 titled Inflation Reduction Act of 2022) which includes some important changes to the Medicare Part D prescription drug coverage.

Some of these changes take effect next year and others over the next several years. I have looked over the text, studied several analysis and have summarized below the 4 changes most likely to Medicare beneficiaries:

  1. Insulin – Effective 2023
  2. Adult Vaccines – Effective 2023
  3. Cap on Out of Pocket Drug Costs – Effective in 2024 and 2025
  4. Medicare to Negotiate Part D and Part B Drug Prices – Effective 2026

Please note: If you are receiving Part D financial assistance through state Medicaid or the Social Security Extra Help program, your benefits may already exceed what is becoming effective in this new bill. Also, if your medications are covered through your VA benefits, you may want to compare these new benefits to what VA covers and compare your options in the years ahead.

1. Insulin – Effective 2023 Beginning in 2023, for Medicare Part D beneficiaries who need insulin, monthly out-of-pocket costs will be capped at $35, and starting in 2026, the cap would be $35 or 25% of the negotiated price if that is lower. And insulin products will no longer subject to a Part D deductible.

2. Adult Vaccines – Effective 2023
Beginning in 2023, Medicare Part D cost-sharing will be eliminated for adult vaccines that are recommended by the Advisory Committee on Immunization Practices. For most clients, the most significant change will be the new $0 Part D copay for the two shot Shingles vaccine, previously covered through Part D however frequently subject to a deductible and higher Tier copay.

3. Cap on Out of Pocket Drug Costs – Effective in 2024 and 2025
For clients with drug costs placing them in the “Coverage Gap” (aka Donut Hole) and Catastrophic Coverage Phase, this change will be very welcomed although phased in over time.

In 2024, that 5% coinsurance payment that now kicks in after someone reaches the catastrophic drug spending level in Medicare will end. As you may imagine, 5% on some of those expensive drugs that cost thousands monthly can be a lot of money. That ends in 2024.

And in 2025 your Medicare Part D out-of-pocket spending will be capped at $2,000 a year, increased to $2,100 in 2026.

4. Medicare to Negotiate Part D and Part B Drug Prices
CMS (Centers for Medicare & Medicaid Services) will be authorized and required to negotiate maximum prices for brand-name drugs that do not have other generic equivalents and that account for the greatest Medicare spending.

There is not yet an official, publicly available list of drugs that Medicare plans to target for negotiations. However Kaiser Family Foundation reports how just a handful of drugs represent the lion’s share of Medicare drug costs. Some likely candidates, based on how much Medicare spent on them in 2020: Eliquis, Xarelto and Januvia.

Today, those brand name drugs that do not have generic equivalents and represent the greatest cost are typically listed as Tier 4 or Tier 5 specialty medications under Medicare Part D coverage.

CMS will begin by negotiating the prices of 10 drugs in 2026, 15 drugs in 2027 and 2028, and 20 drugs in 2029 and each year thereafter. The negotiations would apply first to drugs people get at the pharmacy (Part D), but in the later two years, drugs administered in doctors’ offices (Part B) could also be covered.

If you have any questions or would like for me to review with you your plan benefits please schedule a telephone or Zoom conference convenient for you and direct to my calendar, call us at (518) 346-2115 or send a note to one of our licensed and carrier certified agents closest to you:

Contact Us
First
Last
Permission to Contact
Medicare Permission to Contact (PTC) guidelines require agents to obtain explicit, documented consent from a beneficiary before initiating any unsolicited outreach. The PTC consent expires after 9 months.
1
Your State *
My Licensed Sales Agent (in alphabetical order) *
Are You an Existing Client? *
This helps us prepare for our conversation
How Did You Hear About Us? *

 

Categories
Case Studies Part D Prescription Drug

“Having this EPIC plan was a miracle; an absolute miracle.”

Only a fraction of the nearly 3 million New York State residents aged 65 and older are enrolled in the state’s pharmaceutical assistance program known as New York EPIC.

When I meet with New York Medicare Part D clients, I ask if their individual income is below the $75,000 threshold, $100,000 if married. If so, I advise enrolling in EPIC even if they don’t take any or have only inexpensive medication.  Because, as Schenectady County, New York resident Beth says, “You never know.”

Beth shares her story. The $20,000 per dose medication.

In this 16 minute interview Beth shares her story of how she originally enrolled in EPIC and didn’t use it. She explains how her doctor prescribed a specialty medication. And how that medication was not included on her Medicare Part D plan formulary, its list of covered medications. And when she learned the drug would require a special exception approval from her Medicare Part D plan and costs $20,000 per dose, she was relieved to hear that EPIC would help. Listen in as Beth explains how affordable this $20,000 medication became after EPIC’s help.

Beth: “To me, having this EPIC plan was miracle, an absolute miracle. Because I wouldn’t have been able to get that drug and I would still remain very ill.”

If you reside in New York State, are age 65 or above, and have questions about how EPIC and your Medicare Part D plan can work together, please call (518) 346-2115.